AI assistant
Dishman Carbogen Amcis Limited — Call Transcript 2025
Oct 31, 2025
61199_rns_2025-10-31_5248b59f-8e13-4e61-89d7-c8ea0cc64710.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [451 x 128] intentionally omitted <==
31[st] October, 2025
To, To, Department of Corporate Services The Manager, BSE Ltd . Listing Department, Phiroze Jeejeebhoy Towers, National Stock Exchange of India Ltd. Dalal Street, “Exchange Plaza”, C-1, Block G, Mumbai – 400 001. Bandra-Kurla Complex, Bandra (E), Mumbai – 400 051. Ref.: Scrip Code No. : 540701 (Equity) Ref. : (i) Symbol – DCAL : 975834 and 976560 (Debt) (ii) Series – EQ
SUB: INTIMATION OF CONFERENCE CALL
Dear Sir,
This is to inform that pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, the Company has arranged Conference Call with Investors on Wednesday, 5[th] November, 2025 at 15:00 hrs. (IST) to discuss the financial result and performance of the Company for the quarter and half year ended on 30[th] September, 2025.
The details of Conference Call are attached herewith.
Kindly take the same on your record.
Thanking You, Yours faithfully,
For, Dishman Carbogen Amcis Limited
SHRIMA Digitally signed by SHRIMA GAURANGBHAI GAURANGBHA DAVE I DAVE Date: 2025.10.31 20:32:42 +05'30' Shrima Dave Company Secretary
Encl.: As Above
==> picture [87 x 156] intentionally omitted <==
==> picture [96 x 171] intentionally omitted <==
==> picture [158 x 52] intentionally omitted <==
Dishman Carbogen Amcis Limited to announce its Q2 FY26 results on 04 November 2025. The management of the company to host
Q2 FY26 Earnings Conference Call on
05 November 2025 at 15:00 hrs - 16:00 hrs, IST
==> picture [42 x 41] intentionally omitted <==
Primary Numbers 086 3416 9132 / 086 4536 6496
International Toll-Free Numbers
Singapore - 8001011941 Hong Kong - 800903171
USA - 18773870849 UK - 08000163439
International Participation PIN No.: 4438752#
Pre-Registration Facility (Express Join with DiamondPass[TM] to avoid long queue and save time)
Click here to pre-register for the call and dial in directly without waiting for the operator.
Management Represented by:
Mr. Harshil Dalal
Global CFO
Mr. Stephan Fritschi
Chief Executive Officer, Carbogen Amcis Entities
About Dishman Carbogen Amcis Limited
Established in 1983, Dishman Carbogen Amcis Limited is a fully integrated CDMO (Contract Development and Manufacturing Organisation) company with strong capabilities right from process research & development to late stage clinical and commercial manufacturing and supply of API to innovator pharmaceutical companies. The company has global presence with development and manufacturing sites in Switzerland, UK, France, Netherlands, India, and China.
==> picture [65 x 207] intentionally omitted <==
The company provides end-to-end integrated high-value niche CDMO offering and has comprehensive product offerings which include APIs, High Potent APIs, Intermediates, Phase Transfer Catalysts, Vitamin D Analogues, Cholesterol, Lanolin-related products, Antiseptic and Disinfectant formulations.
For details, please visit www.imdcal.com.
For details please contact:
Harshil Dalal Global CFO P: +91 22 22867597
Krishna Patel Ernst & Young LLP P: +91 9998236402 E: [email protected]